Results 261 to 270 of about 259,922 (311)
Some of the next articles are maybe not open access.
Lower Respiratory Tract Infections
Primary Care: Clinics in Office Practice, 1990Although lower respiratory tract infections are frequently diagnosed in a primary care setting, they are still associated with a significant morbidity and mortality, which warrants a careful approach to treatment. Knowledge of the most common cause based on the age of the patient, location where the infection was acquired, and clinical presentation ...
openaire +2 more sources
Lower Respiratory Tract Infections
PharmacoEconomics, 2003While there is some literature on the cost of specific respiratory infections, much of the existing research focuses only on direct medical treatment costs and does not take into consideration workplace burden due to disability and absenteeism.To evaluate the impact of lower respiratory tract infections (LRTIs) on the workplace, specifically regarding ...
Howard, Birnbaum +4 more
openaire +2 more sources
Enoxacin in lower respiratory tract infections
Journal of Antimicrobial Chemotherapy, 1986In this open, non-comparative study 45 lower respiratory tract infections were treated with the new 4-quinolone, enoxacin. Special attention was paid to infections caused by Pseudomonas aeruginosa. Pseudomonas infections were treated with 600 mg bd. whereas infections caused by other bacteria were treated with 400 mg enoxacin bd.
Wijnands, WJA +4 more
openaire +3 more sources
Biomarkers in lower respiratory tract infections
Pulmonary Pharmacology & Therapeutics, 2010This review aims to provide physicians with an overview of the potential of biomarkers to complement existing clinical severity scores and in conjunction with clinical parameters to improve the diagnosis, risk-stratification and management of lower respiratory tract infections (LRTIs). The usefulness of biomarkers for diagnosing LRTIs is still unclear.
F. Blasi, D. Stolz, F. Piffer
openaire +3 more sources
Pharmacotherapy for lower respiratory tract infections
Expert Opinion on Pharmacotherapy, 2014Bacterial infections play an important role as etiological agents in acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and exacerbations of non-cystic fibrosis (CF) bronchiectasis. In acute bronchitis and asthma exacerbations their role is less well defined than with patients with COPD.
Adamantia, Liapikou +3 more
openaire +2 more sources
Pefloxacin in lower respiratory tract infections
Journal of Antimicrobial Chemotherapy, 1990To determine the efficacy and safety of pefloxacin in the treatment of lower respiratory tract infections, a multicentre trial involving four departments of respiratory diseases was performed. One hundred and eight patients were admitted to the study: most of them were affected with exacerbations of chronic bronchitis or with pneumonia complicating ...
C, Grassi +9 more
openaire +2 more sources
Cefoperazone in Lower Respiratory Tract Infections
Drugs, 198117 hospitalised patients with a wide variety of common lower respiratory tract infections received at least 6 days of intravenous bolus cefoperazone 1.0g 12-hourly. Disease was caused by Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, and mixed anaerobes in 1 patient. All isolates were sensitive to cefoperazone.
C J, Woods, R B, Ellis-Pegler
openaire +2 more sources
Azithromycin and lower respiratory tract infections
Expert Opinion on Pharmacotherapy, 2005Azithromycin is a macrolide antibiotic that has been structurally modified from erythromycin with an expanded spectrum of activity and improved tissue pharmacokinetic characteristics relative to erythromycin. This allows once-daily administration for 3-5 days of treatment compared with traditional multi dosing 7-10-day treatment regimens.
F. Blasi +6 more
openaire +3 more sources
Lower Respiratory Tract Infections
1987The main acute infections of the lower respiratory tract — pneumonia and acute bronchitis — are usually both acquired and treated outside hospital. Admission to hospital occurs when the infection is severe or the patient is otherwise unwell. The same general principles of diagnosis and treatment apply whether the patient is managed in hospital or ...
Anne E. Tattersfield, Martin W. McNicol
openaire +1 more source
Investigation of lower respiratory tract infection
BMJ, 2011As a doctor returning from 16 years in rural practice in the Gambia, I appreciated how Chalmers and Hill discouraged wasteful investigation of presumed lower respiratory tract infection.1Throughout these years I worked beyond reach of chest radiography and blood or sputum culture facilities and used World Health Organization guidelines, which …
openaire +2 more sources